EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Acute Kidney Injury and Electrolyte Imbalances Caused by Dapagliflozin Short-Term Use

António Cabral Lopes, Olga Lourenço iD, Sandra Morgado, Andreia Gaspar, Idalina Freire, Inês Eusébio, João Ribeiro, Mafalda Silva, Marta Mendes, Olímpia Fonseca iD, Rute Duarte, Manuel Morgado iD

Pharmaceuticals · 26.03.2024 · 17 (4) · 420

DOI: 10.3390/ph17040420 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 26.03.2024. Verfasst von António Cabral Lopes und 11 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Services of Local Health Unit of Guarda (ULS da Guarda), 6300-035 Guarda, Portugal. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: national funds through the Portuguese Foundation for Science and Technology/MCTES.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dapagliflozin, a sodium–glucose cotransporter 2 inhibitor (SGLT2i), has shown demonstrated benefits for renal and cardiovascular outcomes in large clinical trials. However, short-term concerns regarding its impact on renal function and electrolyte balance exist. This study aimed to evaluate the short-term effects of dapagliflozin on renal function and electrolyte balance in patients newly prescribed the medication. A retrospective analysis of 246 patients who initiated dapagliflozin therapy was conducted. Serum creatinine, sodium, and potassium levels were measured at baseline (before dapagliflozin) and 5–8 days after initiation (endpoint). A Wilcoxon signed-rank test, Pearson’s chi-square test, and Fischer’s exact test were used for the data analysis. Glycemia and sodium levels were significantly higher at the baseline compared to the endpoint (p < 0.001). Conversely, creatinine and potassium levels were significantly higher at the endpoint than at the baseline (p < 0.001). The prevalence of hyponatremia and hyperkalemia were increased at the endpoint (17.5% vs. 10.2% and 16.7% vs. 8.9%, respectively). Although not statistically significant, a trend towards increased hyponatremia with the co-administration of furosemide was observed (p = 0.089). No significant association was found between potassium-sparing medications (p > 0.05) and hyperkalemia, except for angiotensin receptor blockers (p = 0.017). The combination of dapagliflozin and furosemide significantly increased the risk of acute kidney injury (AKI) at the endpoint (p = 0.006). Age, gender, and chronic kidney disease status did not significantly influence the occurrence of AKI, hyponatremia, or hyperkalemia (p > 0.05). These findings emphasize the importance of the close monitoring of renal function and electrolyte balance, particularly in the early stages of dapagliflozin therapy, especially in patients receiving diuretics or renin–angiotensin–aldosterone system inhibitors.

Schlagwörter

Stichwörter der Autor:innen

T2DMdapagliflozinelectrolyte balancerenal function

Autor:innen und Institutionen

  • Pharmaceutical Services of Local Health Unit of Guarda (ULS da Guarda), 6300-035 Guarda, Portugal.
  • FCS-UBI, Faculty of Health Sciences, University of Beira Interior, 6200-506 Covilhã, Portugal.
  • CICS-UBI, Health Sciences Research Centre, University of Beira Interior, 6200-506 Covilhã, Portugal.
  • Pharmaceutical Services of Local Health Unit of Cova da Beira (ULS Cova da Beira), 6200-251 Covilhã, Portugal.

ORCID-Profile: Olga Lourenço, Olímpia Fonseca, Manuel Morgado

Förderung

  • national funds through the Portuguese Foundation for Science and Technology/MCTES

Zitieren

APA

Lopes, A. C., Lourenço, O., Morgado, S., Gaspar, A., Freire, I., Eusébio, I., Ribeiro, J., Silva, M., Mendes, M., Fonseca, O., Duarte, R., & Morgado, M. (2024). Acute Kidney Injury and Electrolyte Imbalances Caused by Dapagliflozin Short-Term Use. Pharmaceuticals, 17(4), 420. https://doi.org/10.3390/ph17040420

Vancouver

Lopes AC, Lourenço O, Morgado S, Gaspar A, Freire I, Eusébio I, et al. Acute Kidney Injury and Electrolyte Imbalances Caused by Dapagliflozin Short-Term Use. Pharmaceuticals. 2024;17(4):420. doi:10.3390/ph17040420

BibTeX
@article{Lopes2024,
  author = {Lopes, António Cabral and Lourenço, Olga and Morgado, Sandra and Gaspar, Andreia and Freire, Idalina and Eusébio, Inês and Ribeiro, João and Silva, Mafalda and Mendes, Marta and Fonseca, Olímpia and Duarte, Rute and Morgado, Manuel},
  title = {Acute Kidney Injury and Electrolyte Imbalances Caused by Dapagliflozin Short-Term Use},
  journal = {Pharmaceuticals},
  year = {2024},
  volume = {17},
  number = {4},
  pages = {420},
  doi = {10.3390/ph17040420}
}
Kostenlos starten →